150 related articles for article (PubMed ID: 16384817)
1. Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether ("compound A") in rats.
Kharasch ED; Schroeder JL; Bammler T; Beyer R; Srinouanprachanh S
Toxicol Sci; 2006 Apr; 90(2):419-31. PubMed ID: 16384817
[TBL] [Abstract][Full Text] [Related]
2. Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats.
Sheffels P; Schroeder JL; Altuntas TG; Liggitt HD; Kharasch ED
Chem Res Toxicol; 2004 Sep; 17(9):1177-89. PubMed ID: 15377151
[TBL] [Abstract][Full Text] [Related]
3. Evidence for metabolism of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), a sevoflurane degradation product, by cysteine conjugate beta-lyase.
Spracklin DK; Kharasch ED
Chem Res Toxicol; 1996 Jun; 9(4):696-702. PubMed ID: 8831812
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent metabolism of fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), an anesthetic degradation product, to mercapturic acids and 3,3,3-trifluoro-2-(fluoromethoxy)propanoic acid in rats.
Kharasch ED; Jubert C; Spracklin DK; Hoffman GM
Toxicol Appl Pharmacol; 1999 Oct; 160(1):49-59. PubMed ID: 10502502
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl) vinyl ether (Compound A) in a human proximal tubular cell line.
Altuntas TG; Zager RA; Kharasch ED
Toxicol Appl Pharmacol; 2003 Nov; 193(1):55-65. PubMed ID: 14613716
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-conjugation of the sevoflurane degradation product, fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in human liver, kidney, and blood in vitro.
Altuntas TG; Kharasch ED
Toxicol Appl Pharmacol; 2001 Dec; 177(2):85-93. PubMed ID: 11740907
[TBL] [Abstract][Full Text] [Related]
7. P450-dependent and nonenzymatic human liver microsomal defluorination of fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), a sevoflurane degradation product.
Kharasch ED; Hankins DC
Drug Metab Dispos; 1996 Jun; 24(6):649-54. PubMed ID: 8781780
[TBL] [Abstract][Full Text] [Related]
8. Sulfoxidation of cysteine and mercapturic acid conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A).
Altuntas TG; Park SB; Kharasch ED
Chem Res Toxicol; 2004 Mar; 17(3):435-45. PubMed ID: 15025515
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of L-cysteine S-conjugates and N-acetyl-L-cysteine S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in human kidney in vitro: interindividual variability in N-acetylation, N-deacetylation, and beta-lyase-catalyzed metabolism.
Gul Altuntas T; Kharasch ED
Drug Metab Dispos; 2002 Feb; 30(2):148-54. PubMed ID: 11792683
[TBL] [Abstract][Full Text] [Related]
10. Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane.
Jin L; Davis MR; Kharasch ED; Doss GA; Baillie TA
Chem Res Toxicol; 1996 Mar; 9(2):555-61. PubMed ID: 8839062
[TBL] [Abstract][Full Text] [Related]
11. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of the glutathione and cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3, 3-pentafluoro-1-propene (Compound A) in male Fischer 344 rats.
Iyer RA; Baggs RB; Anders MW
J Pharmacol Exp Ther; 1997 Dec; 283(3):1544-51. PubMed ID: 9400032
[TBL] [Abstract][Full Text] [Related]
13. Influence of sevoflurane on the metabolism and renal effects of compound A in rats.
Kharasch ED; Schroeder JL; Sheffels P; Liggitt HD
Anesthesiology; 2005 Dec; 103(6):1183-8. PubMed ID: 16306730
[TBL] [Abstract][Full Text] [Related]
14. Validation of putative genomic biomarkers of nephrotoxicity in rats.
Wang EJ; Snyder RD; Fielden MR; Smith RJ; Gu YZ
Toxicology; 2008 Apr; 246(2-3):91-100. PubMed ID: 18289764
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity of sevoflurane compound A [fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether] in rats: evidence for glutathione and cysteine conjugate formation and the role of renal cysteine conjugate beta-lyase.
Jin L; Baillie TA; Davis MR; Kharasch ED
Biochem Biophys Res Commun; 1995 May; 210(2):498-506. PubMed ID: 7755627
[TBL] [Abstract][Full Text] [Related]
16. Sevoflurane degradation by carbon dioxide absorbents may produce more than one nephrotoxic compound in rats.
Stabernack CR; Eger EI; Warnken UH; Förster H; Hanks DK; Ferrell LD
Can J Anaesth; 2003 Mar; 50(3):249-52. PubMed ID: 12620947
[TBL] [Abstract][Full Text] [Related]
17. Role of renal cysteine conjugate beta-lyase in the mechanism of compound A nephrotoxicity in rats.
Kharasch ED; Thorning D; Garton K; Hankins DC; Kilty CG
Anesthesiology; 1997 Jan; 86(1):160-71. PubMed ID: 9009951
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
Aoyama I; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
[TBL] [Abstract][Full Text] [Related]
19. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays.
Luhe A; Hildebrand H; Bach U; Dingermann T; Ahr HJ
Toxicol Sci; 2003 Jun; 73(2):315-28. PubMed ID: 12700408
[TBL] [Abstract][Full Text] [Related]
20. Altered hippocampal gene expression 2 days after general anesthesia in rats.
Culley DJ; Yukhananov RY; Xie Z; Gali RR; Tanzi RE; Crosby G
Eur J Pharmacol; 2006 Nov; 549(1-3):71-8. PubMed ID: 16979155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]